Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease.
BACKGROUND AND AIMS:The predictive value of traditional risk factors for vascular events in patients with manifest vascular disease is limited, underscoring the need for novel biomarkers to improve risk stratification. Since hematological parameters are routinely assessed in clinical practice, they...
Main Authors: | Daniel Kofink, Steven A Muller, Riyaz S Patel, Jannick A N Dorresteijn, Gijs F N Berkelmans, Mark C H de Groot, Wouter W van Solinge, Saskia Haitjema, Tim Leiner, Frank L J Visseren, Imo E Hoefer, Folkert W Asselbergs, SMART Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6128486?pdf=render |
Similar Items
-
Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
by: Groenhof, T Katrien J, et al.
Published: (2020-04-01) -
Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
by: Anton P van de Woestijne, et al.
Published: (2014-01-01) -
Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
by: Yvo M Smulders, et al.
Published: (2021-03-01) -
Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?
by: Gijs F. N. Berkelmans, et al.
Published: (2020-04-01) -
Relation Between Circulating Inflammatory Chemokines and Vascular Characteristics in Healthy, Young Children
by: Anouk L. M. Eikendal, et al.
Published: (2015-12-01)